CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation.
复制标题
DOI:
10.1172/jci21786
复制
发表时间:
2004
期刊:
影响因子:
--
通讯作者:
G. Abou-Rjaily;S. J. Lee;D. May;Qusai Y. Al-Share;A. DeAngelis;R. Ruch;M. Neumaier;H. Kalthoff;Sue-Hwa Lin;S. Najjar
中科院分区:
文献类型:
--
作者:
G. Abou-Rjaily;S. J. Lee;D. May;Qusai Y. Al-Share;A. DeAngelis;R. Ruch;M. Neumaier;H. Kalthoff;Sue-Hwa Lin;S. Najjar
Phosphorylation of the cell adhesion protein CEACAM1 increases insulin sensitivity and decreases insulin-dependent mitogenesis in vivo. Here we show that CEACAM1 is a substrate of the EGFR and that upon being phosphorylated, CEACAM1 reduces EGFR-mediated growth of transfected Cos-7 and MCF-7 cells in response to EGF. Using transgenic mice overexpressing a phosphorylation-defective CEACAM1 mutant in liver (L-SACC1), we show that the effect of CEACAM1 on EGF-dependent cell proliferation is mediated by its ability to bind to and sequester Shc, thus uncoupling EGFR signaling from the ras/MAPK pathway. In L-SACC1 mice, we also show that impaired CEACAM1 phosphorylation leads to ligand-independent increase of EGFR-mediated cell proliferation. This appears to be secondary to visceral obesity and the metabolic syndrome, with increased levels of output of free fatty acids and heparin-binding EGF-like growth factor from the adipose tissue of the mice. Thus, L-SACC1 mice provide a model for the mechanistic link between increased cell proliferation in states of impaired metabolism and visceral obesity.